导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -0.95% | 582/1050 |
| 近一周 | -2.81% | 738/1104 |
| 近一月 | -6.77% | 790/1102 |
| 近一季 | -11.80% | 753/1092 |
| 近半年 | -5.17% | 617/1070 |
| 近一年 | -2.16% | 624/1018 |
| 近两年 | 42.51% | 559/926 |
| 近三年 | 33.26% | 364/834 |
| 成立以来 | 460.97% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.39% 675/1070 |
24.33% 343/1101 |
- - |
- - |
| 2025 | 25.02% 581/1065 |
0.71% 743/1014 |
4.98% 300/1038 |
26.57% 420/1050 |
-6.57% 776/1065 |
| 2024 | 11.03% 265/1011 |
4.14% 131/960 |
0.84% 252/983 |
10.44% 590/991 |
-4.26% 610/1011 |
| 2023 | -4.40% 190/952 |
0.07% 629/880 |
7.43% 25/895 |
-8.07% 499/915 |
-3.28% 352/952 |
| 2022 | -14.20% 157/867 |
-14.69% 246/773 |
8.28% 341/806 |
-7.18% 113/845 |
0.07% 441/867 |
| 2021 | 16.64% 178/740 |
-6.80% 412/580 |
14.14% 254/659 |
4.51% 132/704 |
4.92% 227/740 |
| 2020 | 75.52% 113/554 |
11.20% 39/419 |
24.47% 201/466 |
9.56% 259/517 |
15.74% 190/554 |
| 2019 | 68.30% 47/410 |
30.24% 365/1149 |
1.85% 177/1231 |
11.56% 87/390 |
13.72% 78/410 |
| 2018 | -23.31% 122/349 |
- - |
- - |
- - |
-11.05% 392/1080 |
| 2017 | 19.00% 86/285 |
- - |
- - |
- - |
- - |
| 2016 | -7.01% 54/205 |
- - |
- - |
- - |
- - |
| 2015 | 31.57% 48/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 景顺长城成长之星股票A VS. 东吴新产业精选股票A(580008) |